🇺🇸 FDA
Patent

US 7198783

Sensitization of neoplastic cells to radiation therapy with reovirus

granted A61KA61K35/765A61K41/0038

Quick answer

US patent 7198783 (Sensitization of neoplastic cells to radiation therapy with reovirus) held by ONCOLYTICS BIOTECH INC. expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K35/765, A61K41/0038, A61P, A61P35/00